跳到正文

Ishara Investments LP 13F 持仓 · 2026年Q2

Ishara Investments 在 2026年Q2(报告期截至 2026-06-30)的 SEC 13F 申报中报告了 41 只证券,申报市值合计 1.36 亿美元。前几大持仓:ACAD(7.62%)、XERS(7.16%)、BMRN(6.03%)。本季前 25 大持仓中:新建仓 9 只、增持 11 只、减持 5 只。

排名代码公司市值占组合股数变动
1ACADACADIA PHARMACEUTICALS INC$10.4M7.62%410,000增持
2XERSXERIS BIOPHARMA HOLDINGS INC$9.7M7.16%1.2M增持
3BMRNBIOMARIN PHARMACEUTICAL INC$8.2M6.03%143,500增持
4PRAXPRAXIS PRECISION MEDICINES I$7.5M5.55%22,550减持
5RAREULTRAGENYX PHARMACEUTICAL IN$6.8M5.03%205,000增持
6AGIOAGIOS PHARMACEUTICALS INC$6.1M4.47%164,000新建仓
7INSMINSMED INC$5.5M4.01%51,250新建仓
8CRNXCRINETICS PHARMACEUTICALS IN$5.4M3.95%143,500新建仓
9ZNTLZENTALIS PHARMACEUTICALS INC$5.0M3.65%1.0M减持
10PCVXVAXCYTE INC$4.8M3.50%82,000增持
11ANNXANNEXON INC$4.7M3.44%820,000增持
12TVTXTRAVERE THERAPEUTICS INC$4.7M3.42%82,000减持
13TNXPTONIX PHARMACEUTICALS HLDG C$4.3M3.17%338,250新建仓
14BBIOBRIDGEBIO PHARMA INC$4.3M3.14%57,400新建仓
15AXSMAXSOME THERAPEUTICS INC.$4.0M2.95%16,400减持
16CTNMCONTINEUM THERAPEUTICS INC$3.4M2.47%205,000增持
17LXRXLEXICON PHARMACEUTICALS INC$3.1M2.24%1.3M增持
18KURAKURA ONCOLOGY INC$3.0M2.23%276,750新建仓
19DBVTDBV TECHNOLOGIES S A$3.0M2.22%184,500增持
20GMABGENMAB A/S$2.8M2.07%102,500增持
21CYTKCYTOKINETICS INC$2.8M2.05%32,800新建仓
22MLYSMINERALYS THERAPEUTICS INC$2.8M2.03%102,500增持
23SLNSILENCE THERAPEUTICS PLC$2.4M1.79%55,350减持
24NUVBNUVATION BIO INC$2.1M1.54%369,000新建仓
25WVEWAVE LIFE SCIENCES LTD$1.9M1.40%328,000新建仓

来源:SEC 13F 申报文件 · 截至 2026-06-30

本期 13F-HR 中的全部持仓,以及相对上季度的变化。

13F 持仓,最新季度

来源SEC EDGAR13F-HR